Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:1567-1572
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warner, J. G.
Right arrow Articles by Little, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warner, J. G., Jr.
Right arrow Articles by Little, W. C.

Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise

James G. Warner, Jr., MD, EdD, FACCa, D. Christopher Metzger, MDa, Dalane W. Kitzman, MD, FACCa, Deborah J. Wesley, RN, BSNa and William C. Little, MD, FACCa

a Cardiology Section, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina 27157-1045, USA



View larger version (27K):

[in a new window]
 
Figure 1 Plot of exercise duration (A) and peak systolic blood pressure (BP) (B) during baseline and during treatment with placebo and losartan. Treatment with losartan increased exercise time and reduced peak systolic BP during exercise compared to baseline and placebo.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement